Small molecular compounds efficiently convert human fibroblasts directly into neurons.

Area of Science:

• Biotechnology
• Neuroscience
• Stem Cell Biology

Background:

• Neurodegenerative diseases lack effective treatments, and current therapies have significant side effects.
• Cell replacement therapy is a promising approach, but generating functional neurons is a critical challenge.

Purpose of the Study:

• To investigate the efficacy of a novel combination of eight small molecules in reprogramming human foreskin fibroblasts (HFFs) into functional neurons in vitro.
• To establish a new method for generating neurons for potential therapeutic applications in neurodegenerative diseases.

Main Methods:

• Human foreskin fibroblasts (HFFs) were cultured and subsequently induced using a conditioned medium containing eight specific small molecules: forskolin, RepSox, SP600125, CHIR99021, Go6983, Y‑27632, IXS9, and I‑BET151.
• Cells were cultured for 30 days, and their morphological, phenotypical, molecular, and electrophysiological properties were analyzed to confirm neuronal differentiation.

Main Results:

• The combined small molecule treatment successfully reprogrammed HFFs into neurons, evidenced by significant morphological and phenotypical changes.
• Induced neurons expressed key neuronal markers (e.g., βIII-tubulin, MAP2) and transcription factors (e.g., NeuroD1, Ascl1), while fibroblast-specific gene expression decreased.
• The reprogrammed cells demonstrated functional electrophysiological properties characteristic of neurons.

Conclusions:

• A novel combination of eight small molecules efficiently induces human fibroblasts to differentiate into neurons in vitro.
• This method provides a valuable tool for generating neurons, potentially advancing cell replacement therapies for neurodegenerative conditions.